IRIS-Coroflex NEO Cohort (IRIS Coroflex)

Seung-Jung Park

Status: Enrolling

Conditions: Coronary Artery Disease; Coronary Artery Stenosis

Treatments: Device: Coroflex ISAR NEO stent

Study type: Observational

Funder types: Other

Identifiers

NCT06177743

AMCCV2023-05

Details and patient eligibility

About

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients ≥ 19 years old
2. Patients receiving Coroflex ISAR NEO stents.
3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion criteria

1. Patients with a mixture of other DESs
2. Terminal illness with life expectancy <1 year.
3. Patients with cardiogenic shock

Trial design

1,000 participants in 1 patient group

Coroflex ISAR NEO

Description:

Patients receiving percutaneous coronary intervention with Coroflex ISAR NEO stents

Treatment:

Device: Coroflex ISAR NEO stent